PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

NIHR review identifies long-term effects of COVID-19

A review from the National Institute for Health Research will analyse the evidence around ongoing COVID-19 symptoms, otherwise referred to as ‘Long Covid’.

The review, drawing on the lived experience of patients and expert consensus on COVID-19, is aiming to improve understanding of the ongoing impact of the disease.

An initial steering group concluded that the widespread perception of COVID-19 is missing the crucial understanding of a distinct pathway experienced by a set of patients – long-term and ongoing effects.

The group also found that there is a lack of consensus on the diagnostic criteria for ongoing COVID-19.

They identified the need for a working diagnosis that is recognised by healthcare services, employers and government agencies to provide a basis for planning appropriate services and allow patients to access support.

In addition, the group found that there are a range of symptoms associated with Long Covid which need to be acknowledged.

The review identified that a common theme to arise was that symptoms occur in one physiological system, such as the heart or lungs, and cease only for symptoms to arise in a different place.

This ‘multisystem’ aspect of COVID-19 needs to be considered both in service provision and in research, according to the NIHR.

The review also highlighted the disproportionate effect of COVID-19 on certain parts of the population, including care home residents.

High mortality rates have also been observed in Black and Asian communities – the review added that each population needed to be included in research to better understand the particular effect COVID-19 has on them.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026